Analysed BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) News Sources
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
08-04-2026
yahoo.com
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
01-04-2026
yahoo.com
How The BioXcel Therapeutics (BTAI) Story Is Shifting With BXCL501 Hopes And Dilution Risks
29-03-2026
yahoo.com
BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting
27-03-2026
yahoo.com
How The BioXcel Therapeutics (BTAI) Story Is Shifting With Dilution Risks And Funding Needs
12-03-2026
yahoo.com
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
11-03-2026
yahoo.com
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
10-03-2026
yahoo.com
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
05-03-2026
yahoo.com
BioXcel Therapeutics to Host Virtual Roundtable Featuring Leading Medical Experts Addressing Latest Developments in Treatment of Acute Agitation in Alzheimer’s Dementia
19-02-2026
yahoo.com
What is the current price of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?
The current price of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is $1.06.
BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) since the previous trading day is $-0.02.
BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) since the previous trading day is -1.8519%.
What is the most recent average sentiment score for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?
The most recent average sentiment score for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?
The most recent sentiment for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is .
SEC-8K** Filing Available For BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.